[RGLS] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
09-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 13.59%
YoY- 35.92%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 0 0 18 18 18 483 3,834 -
PBT -6,033 -6,947 -5,015 -13,847 -21,736 -21,098 -21,037 -18.77%
Tax 1 10 1 118 -128 -8 -2 -
NP -6,034 -6,947 -5,016 -13,847 -21,608 -21,090 -21,035 -18.77%
Tax Rate - - - - - - - -
Total Cost 6,034 6,947 5,034 13,865 21,626 21,573 24,869 -21.00%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 0.00 0.00 -27,866.67 -76,927.78 -120,044.44 -4,366.46 -548.64 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.78 -2.33 -3.00 -15.93 -48.76 -47.95 -49.42 -49.88%
EPS Diluted -0.78 -2.33 -3.00 -15.93 -48.76 -47.95 -49.42 -49.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.